News & Events

International expert in the study of viruses, infectious diseases and cancer to lead ASU’s Biodesign Institute center

October 4, 2016

With an estimated 600,000 cancer deaths in the U.S. this year alone and a looming crisis in antibiotic resistance, there is an urgent societal need to develop novel solutions.  The Biodesign Institute at Arizona State University has hired internationally renowned virologist Grant McFadden to direct a major research initiative that will develop cutting-edge strategies to treat cancer and prevent infectious diseases.  McFadden has been tapped to lead the Biodesign Center for...

11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics

August 18, 2016

Charles Arntzen, Ph.D., Interim Co-director, Biodesign Center for Infectious Diseases and Vaccinology to present a keynote on “Design and Production of Anti-Ebola Vaccines and Therapeutics” and Stephen Albert Johnston, Ph.D., Director, Biodesign Center for Innovations in Medicine, to present a keynote on “Progress Towards a Universal, Preventative Cancer Vaccine” >>Visit conference website 

Molded in clay: new antibacterials to kill germs

August 3, 2016

For more than 20 years microbiologist Shelley Haydel has been interested in antibacterial and antibiotic discovery. While preventing infections with vaccines is incredibly important, she prefers developing new ways to kill infectious bacteria. “In a perfect world, we would have vaccines that prevent all human infections,” she said, “but we don’t live in a perfect world and we don’t have vaccines for all infections yet. In the meantime, we need to continue developing strategies to...

Searching for an HIV Vaccine: A Heterologous Prime-boost System Using Replicating Vaccinia Virus and Plant-produced Virus-like Particles

June 30, 2016

Lydia Meador, Graduate Assistant/Associate, Biodesign Center for Infectious Diseases and Vaccinology The HIV-1 pandemic continues to cause millions of new infections and AIDS-related deaths each year, and a majority of these occur in regions of the world with limited access to antiretroviral therapy. A HIV-1 vaccine is still desperately needed. The most successful HIV-1 clinical trial to date used a non-replicating canarypox viral vector and protein boosting, yet its modest efficacy left...

Switched-on Salmonella: fluid forces guide disease traits of multidrug resistant bacteria

June 8, 2016

Once inside the human body, infectious microbes like Salmonella face a fluid situation. They live in a watery world, surrounded by liquid continually flowing over and abrading their cell surfaces—a property known as fluid shear. In new research appearing in the Nature Publishing Group journal npj Microgravity, Cheryl Nickerson, Ph.D.,  and her colleagues explore the effects of physiological fluid shear on ST313—a particularly dangerous type of Salmonella, which is resistant to...

Superbug: What you need to know

June 1, 2016

ASU researcher explains how realistic all those "end of the world" headlines are Last week the Department of Defense issued a report detailing the case of a 49-year-old Pennsylvania woman who had a rare E. coli infection resistant to all antibiotics, including colistin, which is a harsh drug used only on the sickest patients. The superbug is the first known case of its kind in the United States, and the report sparked strong reactions. The concern was that traits of the infection could...

Student Spotlight: Breanne McCarthy

May 13, 2016

Breanne McCarthy’s undergraduate experience was out of this world - literally.  During her first year at ASU, McCarthy found an opportunity to work in astrobiology in Cheryl Nickerson’s lab at the Biodesign Institute.  “My first study with Dr. Nickerson’s lab was really cool because we were studying...how the spaceflight environment will change bacterial resistance or susceptibility to antibiotics,” said McCarthy, “I actually got to lead a teleconference with our...

Biomedicine and Biotechnology

April 13, 2016

Stephen Johnston, Ph.D., Professor and Co-director, Biodesign Center for Innovations in Medicine; Hugh Mason, Ph.D., Associate Professor, Biodesign Center for Infectious Diseases and Vaccinology; and Carlo Maley, Ph.D., Associate Professor, Virginia G. Piper Biodesign Center for Personalized Diagnostics. The ASU School of Life Sciences is presenting this seminar.  

Inventive ASU faculty recognized for record-breaking year

March 10, 2016

Arizona Technology Enterprises (AzTE) recently celebrated a record-breaking year for the number of inventions, patents and startup companies that have come out of Arizona State University. “The purpose of this event is really to thank ASU’s inventive faculty for their innovation, creativity and hard work,” said Ken Polasko, the executive director at AzTE, ASU’s exclusive intellectual property management and technology transfer organization. During fiscal year 2015, ASU faculty...

Arntzen honored as inaugural 'Rodale 100' recipient

February 2, 2016

Rodale, Inc., a highly influential publisher of some of the most established health and wellness lifestyle brands including Prevention, Men's Health, Women's Health, and Runner's World, has honored ASU Regents' professor Charles Arntzen with its highest honor. Arntzen has been named to the inaugural Rodale 100 list, which celebrates those who share the Rodale, Inc. mission: to inspire health, healing, happiness and love in the world.  Charles...